Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts.

Reneé De WaalHelena RabieKarl-Günter TechnauBrian EleyNosisa SipamboMark CottonAndrew BoulleRobin WoodFrank TanserGeoffrey FattiMatthias EggerMary-Ann Daviesnull null

Published in: Antiviral therapy (2023)

Our data suggest that abacavir may be used safely in infants <28 days old or who weigh <3 kg.

Keyphrases

antiretroviral therapy
hiv positive
randomized controlled trial
hiv infected
human immunodeficiency virus
systematic review
hepatitis c virus
hiv testing
electronic health record
hiv aids
big data
men who have sex with men
machine learning
cross sectional
south africa
deep learning
data analysis